Objective: Application of on-spot staining with brilliant cresyl blue, a supravital stain, was investigated in fine needle aspirates from breast, lymph node and thyroid. Study Design: Patients with palpable breast lumps, lymph nodes and thyroid nodules were included in the study. Brilliant cresyl blue was used to stain the smears, which were evaluated for smear adequacy as well as cytological diagnosis. Smears were decolorized and subjected to Pap and/or HE staining for comparison. Results: Smears which were deemed hemorrhagic on the first attempt with brilliant cresyl blue correlated with Pap staining; then sites were reaspirated within minutes to obtain satisfactory cellular smears. Morphologically, cells which were designated malignant on supravital staining were mostly malignant on Pap/HE staining. Conclusion: On-spot brilliant cresyl blue staining increases the diagnostic potential on preliminary examination by decreasing the staining time and is as good as conventional stains in exhibiting cellular morphology.
Kikuchi disease (KD) is an enigmatous, self-limiting, rarely fatal, disease of young females. The self-limiting disorder usually occurs in Asian women in their late 20s or early 30s. Typically it runs a benign course and appears to resolve spontaneously one to six months after definitive diagnosis. We report a 27 years old lady presenting with cervical lymphadenopathy. Fine needle aspiration cytology of the node clinched the diagnosis revealing crescentic histiocytes, plasmacytoid monocytes, extracellular (karyorrhectic) debris and necrosis. The diagnosis was subsequently confirmed by histopathology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.